3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE, 95%, 500mg

(S)-3-Amino-4-(m-tolyl)butanoic acid hydrochloride, 95.0%, 1g

3-Phenoxypropyl bromide, 96.0%, 100g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

4-[[2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine, 95%, 1g

(5-Bromo-2-methylphenyl)methanamine hydrochloride, 5g

N'-Hydroxybenzimidamide, 97%, 5g

(3-Chloro-4-(isopropylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

BENZYL 4-OXOCYCLOHEXANECARBOXYLATE, 95.0%, 250mg

Narrow mouth bottle 301, 3000 ml, 32 mm, 1 Piece

4-formyl-2-methoxyphenyl cyclopropanecarboxylate, 100mg

Pyridine-4-aldoxime>98.0%(T)10g

1,4,5,6-Tetrahydrocyclopenta[c]pyrazole-3-carbohydrazide, 95.0%, 1g